ABSTRACT

Patients presenting with diffuse coronary artery disease pose a difficult treatment challenge and a number of different revascularization strategies have been employed with variable success. The development of bioresorbable scaffolds (BRSs) provides the clinician with an additional management option and has already been demonstrated to be both viable and feasible in this clinical setting. There are a number of potential advantages of utilizing BRS in the treatment of diffuse coronary artery disease. There are some limitations of current BRS devices that require consideration. Due to current device design and the specific challenges of treating diffuse disease, a number of practical considerations should be taken into account when opting to treat diffuse coronary artery disease with BRS. Appropriate postdilatation will facilitate embedment of the struts into the vessel wall partially counteracting the impact of greater strut thickness.